Haluk Cinakli

Haluk Cinakli

Auto-generated profile, based on publicly available information

Haluk Cinakli

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, İzmir Katip Çelebi University, İzmir, Turkey.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2023 in Rheumatology
Verified
Journal Article
Closed access
PDF file
BYBurcu Yagiz
Burcu Yagiz
NLNihal Lermi
Nihal Lermi
BCBelkis Nihan Coşkun
Belkis Nihan Coşkun
EDEdiz Dalkilic
Ediz Dalkilic
SKSedat Kiraz
Sedat Kiraz
YPYavuz Pehlivan
Yavuz Pehlivan
Objectives: The objectives of this study were to assess the clinical characteristics, predictive factors, and practical algorithms of paradoxical reactions (PRs), specifically paradoxical psoriasis (PP). Methods: The TReasure database is a web-based prospective observational cohort comprised of patients with RA and SpA from 17 centres around Turkey since 2017. A cohort study and a case–control study nestled within the cohort were identified. Results: In total, 2867 RA and 5316 SpA patients were evaluated. The first biologic agent was found to have caused PRs in 60% of the 136 patients (1.66%) who developed the PRs. The median time interval between the PRs and biological onset was 12 months (range 1–132 months, mean 21 months). The most common types of PP, constituting 92.6% of PRs, were pustular (60.3%) and palmoplantar (30.9%). Adalimumab (30.9%), infliximab (19%) and etanercept (17.4%) were the most common agents causing the PP. In the treatment of most PP patients (73.2%), switching biologic agents was favoured, with TNF inhibitor (TNFi) chosen in 46.03% and non-TNFi in 26.9% of cases. The three most frequently selected drugs were etanercept (24.6%), secukinumab (9.5%) and adalimumab (8.7%). Only 5.17% of patients who switched to another TNFi showed progression. The odds ratios (s) for SSZ, HCQ, and LEF use were significantly higher in RA controls than in PP patients (P = 0.033, OR = 0.15; P = 0.012, OR = 0.15; and P = 0.015, OR = 0.13, respectively). In the PP group with SpA, the number of smokers was significantly higher (P = 0.003, OR: 2.0, 95% CI: 1.05, 3.81). Conclusion: Contrary to expectations based on earlier research suggesting that paradoxical reactions develop with the class effect of biological agents, the response of patients who were shifted to another TNFi was favourable.

31 March 2025 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
GAGülay Alp
Gülay Alp
IAİdIl Kurut Aysin
İdIl Kurut Aysin
HCHaluk Cinakli
Haluk Cinakli
DSDilek Solmaz
Dilek Solmaz
SAServet Akar
Servet Akar
Objectives: This study aims to evaluate the frequency of central sensitization (CS) and neuropathic pain (NP) in psoriatic arthritis (PsA) and their association with disease activity and functional disability. Patients and methods: Between April 2022 and August 2022, data of a total of 114 consecutive patients (78 males, 36 females; mean age: 49±11.5 years; range, 22 to 76 years) who were diagnosed with PsA according to the classification criteria for PsA criteria were prospectively analyzed. CS was assessed using the Central Sensitization Inventory (CSI), with scores ≥40 indicating its presence. Neuropathic pain was evaluated using the Douleur Neuropathique en 4 Questions (DN4), with scores ≥4 indicating its presence. Results: The median disease duration was 4 (interquartile range: 9) years. Among 114 patients, CS was present in 43% and NP in 23.5%. Fibromyalgia syndrome (FMS) was diagnosed in 25.5%. Patients with CS or NP had higher Visual Analog Scale pain scores, patient and physician global assessments, tender joint counts, disease activity scores in PsA, and Health Assessment Questionnaire Disability Index (HAQ-DI). Central sensitization was also associated with enthesitis, nail involvement, and depression, while NP was linked to higher body mass index (BMI). Anxiety, depression, and HAQ-DI were independent risk factors for CS, while BMI and FMS were correlated with NP. Conclusion: Our study results suggest that CS and NP are prevalent in PsA and are associated with worse disease outcomes. Recognizing and addressing these conditions may enhance the management of patients with refractory symptoms and unmet treatment goals.

7 January 2024 in Musculoskeletal Care
Verified
Journal Article
Closed access
GAGülay Alp
Gülay Alp
HCHaluk Cinakli
Haluk Cinakli
SAServet Akar
Servet Akar
DSDilek Solmaz
Dilek Solmaz

5 April 2023 in Somatosensory & Motor Research
Verified
Journal Article
Closed access
HCHaluk Cinakli
Haluk Cinakli
AYAlparslan Yetisgin
Alparslan Yetisgin
DDDilek Sen Dokumaci
Dilek Sen Dokumaci
ABAhmet Boyaci
Ahmet Boyaci
To investigate the effects of adding interactive videogames to conventional rehabilitation programmes on radiological progression and upper extremity functional status.A total of 18 patients with h...

28 January 2026 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
HCHaluk Cinakli
Haluk Cinakli
MKMete Kara
Mete Kara
GAGülay Alp
Gülay Alp

7 March 2024 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
HCHaluk Cinakli
Haluk Cinakli
EEElif Durak Ediboglu
Elif Durak Ediboglu
DSDilek Solmaz
Dilek Solmaz
SAServet Akar
Servet Akar